Description
Sematide Injection (Semaglutide) by Ferozsons Laboratories is a glucagon-like peptide-1 (GLP-1) receptor agonist available in doses of 0.25mg, 0.5mg, and 1mg for subcutaneous injection. It works by stimulating insulin secretion, suppressing glucagon release, and slowing gastric emptying, leading to better blood glucose control and reduced appetite. Primarily indicated for the management of type 2 diabetes mellitus, and also aids in weight reduction as a beneficial side effect. Administered once weekly, it offers a convenient dosing schedule with proven cardiovascular benefits in diabetic patients.
Reviews
There are no reviews yet.